To my friends,
My boys bought me a $400 MRI (Calcium Score) a test to see if my arteries were candidates for plaque. Well, this 53yr. old who finished well at our Michigan Masters meet didn't do well on his test. The score goes from 1 to 100 and the closer you get to 100 the chances of plaque in the arteries goes up. I ended up with a 99 and won a visit to a cardiologist who ran a MRI / Stress test. The good news is the drug I'm on (Vitorin) lowered my bad cholesterol and triglicyrides by 1/2 213 to 113 and 113 to 58. Don't wait my friends, get the calcium score and get some piece of mind. I may die today, but heck, I know I tried and I tried to spread the word..
I'm still lifting, biking, and swimming. Running the good race?? :angel::angel::angel:
Parents
Former Member
Nevertheless, relevant prognostic information obtained may be useful to initiate or intensify appropriate treatment strategies to slow the progression of existing atherosclerotic vascular disease. Current data suggest intermediate-risk patients may benefit most from further risk stratification with cardiac CT, as CAC testing is effective at identifying increased risk and in one study motivating effective behavioral changes. Randomized clinical trials will help determine if selective use of cardiac CT in the intermediate-risk patient would lead to more appropriate use of pharmacologic therapy and improved clinical outcomes.
I think this is the take home message.
The problem with cardiac CT is that it can lead to additional, possibly unnecessary, studies.
Nevertheless, relevant prognostic information obtained may be useful to initiate or intensify appropriate treatment strategies to slow the progression of existing atherosclerotic vascular disease. Current data suggest intermediate-risk patients may benefit most from further risk stratification with cardiac CT, as CAC testing is effective at identifying increased risk and in one study motivating effective behavioral changes. Randomized clinical trials will help determine if selective use of cardiac CT in the intermediate-risk patient would lead to more appropriate use of pharmacologic therapy and improved clinical outcomes.
I think this is the take home message.
The problem with cardiac CT is that it can lead to additional, possibly unnecessary, studies.
